Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127215251 | 12721525 | 1 | I | 2015 | 20160413 | 20160907 | 20160907 | EXP | PHHY2016BR054353 | NOVARTIS | 19.22 | YR | M | Y | 74.00000 | KG | 20160907 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127215251 | 12721525 | 1 | PS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 3 DF, QD (FROM 12 YEARS) | 10187 | 3 | DF | TABLET | QD | ||||||
| 127215251 | 12721525 | 2 | SS | RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | EXTENDED RELEASE CAPSULES | QD | ||||||
| 127215251 | 12721525 | 3 | C | TOFRANIL | IMIPRAMINE HYDROCHLORIDE | 1 | Unknown | 25 MG, UNK | Y | 0 | 25 | MG | |||||||
| 127215251 | 12721525 | 4 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, UNK | U | 0 | 75 | MG | |||||||
| 127215251 | 12721525 | 5 | C | AAS | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | TABLET | QD | ||||||
| 127215251 | 12721525 | 6 | C | AAS | ASPIRIN | 1 | 0 | TABLET | |||||||||||
| 127215251 | 12721525 | 7 | C | BUP | BUPROPION HYDROCHLORIDE | 1 | Unknown | 150 MG, QD | U | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127215251 | 12721525 | 1 | Attention deficit/hyperactivity disorder |
| 127215251 | 12721525 | 2 | Attention deficit/hyperactivity disorder |
| 127215251 | 12721525 | 3 | Product used for unknown indication |
| 127215251 | 12721525 | 4 | Product used for unknown indication |
| 127215251 | 12721525 | 5 | Blood disorder |
| 127215251 | 12721525 | 6 | Ischaemic stroke |
| 127215251 | 12721525 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127215251 | 12721525 | OT |
| 127215251 | 12721525 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127215251 | 12721525 | Aggression | |
| 127215251 | 12721525 | Anxiety | |
| 127215251 | 12721525 | Blood pressure increased | |
| 127215251 | 12721525 | Decreased appetite | |
| 127215251 | 12721525 | Depression | |
| 127215251 | 12721525 | Drug ineffective | |
| 127215251 | 12721525 | Hypersomnia | |
| 127215251 | 12721525 | Insomnia | |
| 127215251 | 12721525 | Ischaemic stroke | |
| 127215251 | 12721525 | Learning disability | |
| 127215251 | 12721525 | Memory impairment | |
| 127215251 | 12721525 | Vein disorder | |
| 127215251 | 12721525 | Visual field defect | |
| 127215251 | 12721525 | Visual impairment | |
| 127215251 | 12721525 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127215251 | 12721525 | 2 | 201604 | 0 | ||
| 127215251 | 12721525 | 5 | 201503 | 0 |